2024
DOI: 10.55374/jseamed.v8.201
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and Predictive Factors of Neutropenia Among Patients With Breast Cancer Receiving Doxorubicincyclophosphamide Chemotherapy at a Cancer Center, Surin Hospital: A Retrospective Case-Control Study

Chalermchai Lertanansit,
Kaweewat Aekpongsan,
Panwassa Puapan

Abstract: Background: Despite significant advancements in breast cancer treatment with targeted therapy and immunotherapy, chemotherapy remains a crucial component across all stages. Anthracycline-based chemotherapy, while commonly administered, can lead to severe and potentially fatal complications such as febrile neutropenia. Objectives: This study aimed to investigate the prevalence and predictive factors for developing neutropenia in patients with breast cancer undergoing an anthracycline-based chemotherapy regimen.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 13 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?